Mengchao Wu

Second Military Medical University — China

Medicine · Health Sciences

69h-index18.5kcitations495works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(187), Cholangiocarcinoma and Gallbladder Cancer Studies(115), Liver Disease Diagnosis and Treatment(89), Hepatitis B Virus Studies(51), Virus-based gene therapy research(49)

Publications495 total

[Expression of Concern] Inhibition of tumorigenesis and invasion of hepatocellular carcinoma by siRNA‑mediated silencing of the <i>livin</i> gene
Molecular Medicine Reports·2025Open Access
Data from Gut-Derived Lipopolysaccharide Promotes T-Cell–Mediated Hepatitis in Mice through Toll-Like Receptor 4
2023Open Access
Data from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Supplementary Table S3 from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Supplementary Table S2 from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Conflict of Interest Form from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Conflict of Interest Form from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Supplementary Table 1, Methods from Gut-Derived Lipopolysaccharide Promotes T-Cell–Mediated Hepatitis in Mice through Toll-Like Receptor 4
2023Open Access
Supplementary Table S1 from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Supplementary Table 1, Methods from Gut-Derived Lipopolysaccharide Promotes T-Cell–Mediated Hepatitis in Mice through Toll-Like Receptor 4
2023Open Access
Perspective on This Article from Gut-Derived Lipopolysaccharide Promotes T-Cell–Mediated Hepatitis in Mice through Toll-Like Receptor 4
2023Open Access
Supplementary Table S2 from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Supplementary Table S1 from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Perspective on This Article from Gut-Derived Lipopolysaccharide Promotes T-Cell–Mediated Hepatitis in Mice through Toll-Like Receptor 4
2023Open Access
Data from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Data from Gut-Derived Lipopolysaccharide Promotes T-Cell–Mediated Hepatitis in Mice through Toll-Like Receptor 4
2023Open Access
Supplementary Table S3 from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Supplementary Data from COOH-Terminal Truncated HBV X Protein Plays Key Role in Hepatocarcinogenesis
2023Open Access
Data from ICAM-1–Related Noncoding RNA in Cancer Stem Cells Maintains ICAM-1 Expression in Hepatocellular Carcinoma
2023Open Access
Data from Methylation of &lt;i&gt;Tip30&lt;/i&gt; Promoter Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma
2023Open Access
page 1 of 25Next →

Frequent Co-authors

Hongyang Wang(15), Feng Shen(14), Wan Yee Lau(12), Tian Yang(11), Lei Chen(8), Shuqun Cheng(7), Le‐Xing Yu(6), He‐Xin Yan(6), Yong Xia(5), Xuying Wan(5), W. Y. Lau(5), Liang Tang(5), Wen Yang(5), Eric C. H. Lai(5), Weiping Zhou(5), Liang Hu(5), Yan–Xin Chang(5), Kui Wang(4), Wei‐Xing Guo(4), Jie Xue(4)